Life Sciences Archives - EverGlade

Life Sciences

BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics

Leave a Comment / All Posts, BARDA, Defense, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a pre-solicitation notice for a potential future project opportunity: TACTIC, or Threat-Agnostic CBRN Therapeutics. The anticipated effort would support development of therapeutics that address host dysregulation caused by chemical, biological, radiological, and nuclear, or CBRN, threats. BARDA is […]

BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics Read More »

BARDA’s Draft New Vaccine Platforms RPP Signals a Major Push for Adaptable Medical Countermeasures

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has released a draft Request for Project Proposals (RPP), RRPV 26-05-NVP: “New Vaccine Platforms,” through the Rapid Response Partnership Vehicle (RRPV). The draft opportunity seeks mature, adaptable vaccine platform technologies that can help the United States prepare for emerging infectious disease threats before and during public health

BARDA’s Draft New Vaccine Platforms RPP Signals a Major Push for Adaptable Medical Countermeasures Read More »

BARDA Releases RFP for Pandemic Influenza Vaccine Medical Countermeasures

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has released a new Request for Proposals, Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response. The solicitation seeks partners to support the development, manufacturing, stockpiling, regulatory readiness, and rapid deployment of influenza vaccine medical countermeasures during a pandemic or other public health emergency. BARDA’s objective is

BARDA Releases RFP for Pandemic Influenza Vaccine Medical Countermeasures Read More »

NSF’s $1.5B Foundational Research Funds: Where the Next Wave of Science and Technology Will Start

Leave a Comment / All Posts, Emerging Technologies, Industry News, Life Sciences, NSF / By

The U.S. National Science Foundation has released 12 new Notices of Funding Opportunity totaling more than $1.5 billion for foundational research. The announcements span biological sciences, computing, engineering, geosciences, mathematics, materials, physics, chemistry, and astronomy. This is not a single funding program, and it should not be read as one. It is a coordinated signal

NSF’s $1.5B Foundational Research Funds: Where the Next Wave of Science and Technology Will Start Read More »

ARPA-H STREAM Program: A New Federal Push for Safer, Smarter Weed Management

Leave a Comment / All Posts, ARPA-H, Emerging Technologies, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) has launched the Systems for Tracking and Resilience in Efficient Agricultural-input Management (STREAM) program, a new effort focused on reducing herbicide exposure across the food system without making farming less productive or food less affordable. STREAM starts with a practical problem: herbicides remain essential tools for many

ARPA-H STREAM Program: A New Federal Push for Safer, Smarter Weed Management Read More »

BARDA’s BioMaP-Consortium Seeks Vendor Managed Inventory Capabilities to Secure the Nation’s API Reserve

Leave a Comment / All Posts, BARDA, Emerging Technologies, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), has released Request for Project Proposals (RPP) 26-12-VMI, “Ensuring American Pharmaceutical Supply Chain Resilience through Vendor Managed Inventory Capabilities for Active Pharmaceutical Ingredients Used in Medical Countermeasure Finished Dose Form Drug Products.” Issued by the Administration for Strategic Preparedness and

BARDA’s BioMaP-Consortium Seeks Vendor Managed Inventory Capabilities to Secure the Nation’s API Reserve Read More »

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing

Leave a Comment / All Posts, BARDA, Industry News, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has been telegraphing its priorities for years, but the latest cluster of moves makes the picture sharper: the U.S. is shifting from “buy vaccines when a crisis hits” to owning the infrastructure that keeps pandemic response on a hair trigger. Three signals stand out: A new pre‑solicitation

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing Read More »

MTEC’s FY26 Multi‑Topic RPP: Where Military Medicine, Prevention, And Infectious Disease Innovation Converge

Leave a Comment / All Posts, Defense, Life Sciences, MTEC / By

The Medical Technology Enterprise Consortium (MTEC) has released its Fiscal Year 2026 Multi‑Topic Request for Project Proposals (MTEC‑26‑04‑MultiTopic), opening a wide lane for medical prototype and knowledge solutions that directly support force health and readiness. Enhanced White Papers are due October 30, 2026 at noon Eastern, and awards will be made under MTEC’s prototype OTA

MTEC’s FY26 Multi‑Topic RPP: Where Military Medicine, Prevention, And Infectious Disease Innovation Converge Read More »

DARPA Releases Official Solicitation for Protein ENGineering (PENG)

Leave a Comment / All Posts, DARPA, Defense, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), under the Defense Sciences Office (DSO), has released the full Program Solicitation for Protein ENGineering (PENG), DARPA-PS-26-129. The solicitation moves PENG from concept and Proposers Day into an active, multi‑phase program seeking innovative proposals to build a multifunctional, target‑agnostic platform for precise, programmable editing of endogenous proteins. PENG’s

DARPA Releases Official Solicitation for Protein ENGineering (PENG) Read More »

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves

Leave a Comment / All Posts, BARDA, Life Sciences / By

ASPR And BARDA Move To Close The Nitrile Glove Gap The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑09‑Gloves) focused on Expansion of Domestic Manufacturing Capacity for Nitrile Gloves. ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC)

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves Read More »

Sustaining Nitrile Glove Capacity With BARDA’s PPE Manufacturing Push

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), working through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑04‑NBR) focused on Sustainment of PPE Capacities – Nitrile Butadiene Rubber (NBR). ASPR’s Industrial Base Management and Supply Chain (IBMSC) is seeking projects that will sustain and strengthen domestic NBR

Sustaining Nitrile Glove Capacity With BARDA’s PPE Manufacturing Push Read More »

ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑158 for ASCENT‑IBO: Accelerating Safe Clinical Evaluation of Novel Treatments – Ibogaine for Better Outcomes in OUD. This effort sits under the Proactive Health Office (PHO) Innovative Solutions Opening (ISO ARPA‑H‑SOL‑24‑106) and is directly tied to Executive Order 14401, which directs federal agencies

ARPA‑H’s ASCENT‑IBO Initiative: Accelerating Ibogaine Trials For Opioid Use Disorder Read More »

Scroll to Top